{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T03:29:17Z","timestamp":1767410957148,"version":"3.48.0"},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,1,1]]},"DOI":"10.2169\/internalmedicine.5301-25","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T18:08:46Z","timestamp":1751479726000},"page":"183-186","source":"Crossref","is-referenced-by-count":0,"title":["Four Metachronous Cancers: Mutation Profiling Can Be Used to Distinguish Multiple Primary Cancers from Metastases"],"prefix":"10.2169","volume":"65","author":[{"given":"Etsuko","family":"Hisanaga","sequence":"first","affiliation":[{"name":"Clinical Department of Pathology, Gunma University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Sano","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Graduate School of Gunma University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Yokoo","sequence":"additional","affiliation":[{"name":"Clinical Department of Pathology, Gunma University Hospital, Japan"},{"name":"Department of Pathology, Graduate School of Gunma University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. National Comprehensive Cancer Network. NCCN clinical practice Guidelines in Oncology (NCCN Guidelines<sup>\u00ae<\/sup>) Occult primary [Cancer of Unknown Primary (CUP)]. version 1. NCCN, Philadelphia, 2024."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kim JY, Jung J, Kim KM, Lee J, Im YH. <i>TP53<\/i> mutations predict poor response to immunotherapy in patients with metastatic solid tumors. Cancer Med 12: 12438-12451, 2023.","DOI":"10.1002\/cam4.5953"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hainaut P, Pfeifer GP. Somatic <i>TP53<\/i> mutations in the era of genome sequencing. Cold Spring Harb Perspect Med 6: a026179, 2016.","DOI":"10.1101\/cshperspect.a026179"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kamoun A, de Reyni\u00e8s A, Allory Y, et al. A consensus molecular classification of muscle-invasive bladder cancer. Eur Urol 77: 420-433, 2020.","DOI":"10.1016\/j.eururo.2019.11.011"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sakamoto I, Hirotsu Y, Amemiya K, Nozaki T, Mochizuki H, Omata M. Elucidation of genomic origin of synchronous endometrial and ovarian cancer (SEO) by genomic and microsatellite analysis. J Gynecol Oncol 34: e6, 2023.","DOI":"10.3802\/jgo.2023.34.e6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Murage NW, Ahmed NM, Underwood TJ, Walters ZS, Breininger SP. The genetic profile and molecular subtypes of human pseudomyxoma peritonei and appendiceal mucinous neoplasms: a systematic review. Cancer Metastasis Rev 42: 335-359, 2023.","DOI":"10.1007\/s10555-023-10088-0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gupta S, Khan S, Kawka M, et al. Clinical utility of clonal origin determination in managing recurrent hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol 15: 1159-1167, 2021.","DOI":"10.1080\/17474124.2021.1967144"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Saab J, Zia H, Mathew S, Kluk M, Narula N, Fernandes H. Utility of genomic analysis in differentiating synchronous and metachronous lung adenocarcinomas from primary adenocarcinomas with intrapulmonary metastasis. Transl Oncol 10: 442-449, 2017.","DOI":"10.1016\/j.tranon.2017.02.009"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yang CY, Yeh YC, Wang LC, et al. Genomic profiling with large-scale next-generation sequencing panels distinguishes separate primary lung adenocarcinomas from intrapulmonary metastases. Mod Pathol 36: 100047, 2023.","DOI":"10.1016\/j.modpat.2022.100047"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Patel SB, Kadi W, Walts AE, et al. Next-generation sequencing: a novel approach to distinguish multifocal primary lung adenocarcinomas from intrapulmonary metastases. J Mol Diagn 19: 870-880, 2017.","DOI":"10.1016\/j.jmoldx.2017.07.006"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zheng R, Shen Q, Mardekian S, Solomides C, Wang ZX, Evans NR. Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer. J Thorac Cardiovasc Surg 160: e71-e79, 2020.","DOI":"10.1016\/j.jtcvs.2019.11.126"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Romano C, Di Gregorio S, Pennisi MS, et al. Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis. Mol Biol Rep 49: 9059-9064, 2022.","DOI":"10.1007\/s11033-022-07630-8"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Rao C, Nie L, Miao X, Lizaso A, Zhao G. Targeted sequencing identifies the mutational signature of double primary and metastatic malignancies: a case report. Diagn Pathol 14: 101, 2019.","DOI":"10.1186\/s13000-019-0874-5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Furukawa K, Hatakeyama K, Terashima M, et al. Report of two patients in whom comparisons of the somatic mutation profile were useful for the diagnosis of metastatic tumors. Surg Case Rep 8: 214-220, 2022.","DOI":"10.1186\/s40792-022-01566-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Xue L, Li W, Fan X, et al. Identification of second primary tumors from lung metastases in patients with esophageal squamous cell carcinoma using whole-exome sequencing. Theranostics 10: 10606-10618, 2020.","DOI":"10.7150\/thno.45311"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nyqvist J, Persson F, Parris TZ, et al. Metachronous and synchronous occurrence of 5 primary malignancies in a female patient between 1997 and 2013: a case report with germline and somatic genetic analysis. Case Rep Oncol 10: 1006-1012, 2017.","DOI":"10.1159\/000484403"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/1\/65_5301-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T03:26:21Z","timestamp":1767410781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/1\/65_5301-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5301-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"5301-25"}}